{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T22:32:14Z","timestamp":1765233134994,"version":"build-2065373602"},"reference-count":13,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Society of Cytopathology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.jasc.2021.06.004","type":"journal-article","created":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T05:55:19Z","timestamp":1623909319000},"page":"565-570","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["The significance of ASC-H and LSIL dual interpretation with risk stratification: one institution experience"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9484-3508","authenticated-orcid":false,"given":"Abel A.","family":"Gonzalez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8309-1267","authenticated-orcid":false,"given":"Akosua","family":"Ametorgoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"Hamele-Bena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sedef","family":"Everest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renu","family":"Virk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adel","family":"Cimic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5498-2287","authenticated-orcid":false,"given":"Patricia","family":"Tiscornia-Wasserman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jasc.2021.06.004_bib1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/cncy.21521","article-title":"The Pap test and Bethesda 2014","volume":"123","author":"Nayar","year":"2015","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2021.06.004_bib2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1309\/AJCPM9X5RCZYEQJQ","article-title":"Low-grade squamous intraepithelial lesion\/cannot exclude high-grade squamous intraepithelial lesion (LSIL-H) is a unique category of cytologic abnormality associated with distinctive HPV and histopathologic CIN 2+ detection rates","volume":"141","author":"Barron","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jasc.2021.06.004_bib3","first-page":"13","article-title":"\"Low-grade squamous intraepithelial lesion, cannot exclude high-grade:\" TBS says \"Don't Use It!\" Should I really stop it?","volume":"14","author":"Chiaffarano","year":"2017","journal-title":"Cytojournal"},{"key":"10.1016\/j.jasc.2021.06.004_bib4","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ygyno.2010.12.004","volume":"121","author":"Ince","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jasc.2021.06.004_bib5","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/cyt.12351","article-title":"Overall accuracy of cervical cytology and clinicopathological significance of LSIL cells in ASC-H cytology","volume":"28","author":"Kim","year":"2017","journal-title":"Cytopathology"},{"key":"10.1016\/j.jasc.2021.06.004_bib6","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/cncr.22169","article-title":"The significance of \"low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion\" as a distinct squamous abnormality category in Papanicolaou tests","volume":"108","author":"Elsheikh","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.jasc.2021.06.004_bib7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1742-6413-4-7","article-title":"Should LSIL with ASC-H (LSIL-H) in cervical smears be an independent category? A study on SurePath specimens with review of literature","volume":"4","author":"Shidham","year":"2007","journal-title":"Cytojournal"},{"issue":"5 suppl","key":"10.1016\/j.jasc.2021.06.004_bib8","first-page":"378","article-title":"Clinical outcomes of patients with a cytologic interpretation of \u2018\u2018LSIL, cannot exclude HSIL (LSIL-H)\u2019\u2019 in Pap tests: a retrospective follow-up study [abstract]","volume":"108","author":"Underwood","year":"2006","journal-title":"Cancer (Cancer Cytopathol)"},{"key":"10.1016\/j.jasc.2021.06.004_bib9","first-page":"92","article-title":"Clinical significance of the diagnosis of low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion","volume":"117","author":"Alsharif","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.jasc.2021.06.004_bib10","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1309\/QRDNMWWAKJQTVJGF","article-title":"Low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion\" is a distinct cytologic category: histologic outcomes and HPV prevalence","volume":"128","author":"Owens","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jasc.2021.06.004_bib11","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jasc.2021.06.004_bib12","first-page":"7","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jasc.2021.06.004_bib13","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/cncy.21210","article-title":"Should LSIL-H be a distinct cytology category?: A study on the frequency and distribution of 40 human papillomavirus genotypes in 808 women","volume":"120","author":"Zhou","year":"2012","journal-title":"Cancer Cytopathol"}],"container-title":["Journal of the American Society of Cytopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213294521000636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213294521000636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T06:46:52Z","timestamp":1761979612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213294521000636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":13,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S2213294521000636"],"URL":"https:\/\/doi.org\/10.1016\/j.jasc.2021.06.004","relation":{},"ISSN":["2213-2945"],"issn-type":[{"type":"print","value":"2213-2945"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The significance of ASC-H and LSIL dual interpretation with risk stratification: one institution experience","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Society of Cytopathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jasc.2021.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Society of Cytopathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}